Florez H, Valbuena H, Ryder E, Rincón E, Campos G, Castillo S, González J, Fernández V, Raleigh X, Gómez M E
Instituto de Investigaciones Clínicas, Facultad de Medicina, Universidad del Zulia, Maracaibo, Venezuela.
Invest Clin. 1995 Sep;36(3):131-47.
To determine the most frequent dyslipidemias among first-degree relatives of NIDDM patients, and its association with their glucose-tolerance status and hyperinsulinemia, we have started to examine members of NIDDM pedigrees, according to American Diabetes Association guidelines for nuclear family studies. In a large family with 2 NIDDM siblings in the 2nd generation, and 4 siblings with NIDDM in the 3rd generation, we have evaluated 14 first degree relatives and also 15 sex and aged matched healthy control subjects without family history of diabetes. The NIDDM relative group presented BMI = 31.8 +/- 3.9 kg/m2, SBP = 128 +/- 18.2 mmHg, DBP = 84 +/- 12.7 mmHg. Both relatives and controls were subjected to a 2h 75g OGTT for glucose and insulin determinations. Although none of NIDDM relatives has IGT, both Glycemic Area (GA) and Insulin Area (IA) were greater (p < 0.01) in the NIDDM relative group. The Insulin/Glucose ratio was also higher (p < 0.01) at 0 and 120 min of OGTT, this might be indirect evidence of Insulin- Resistance. Fasting serum lipids in the NIDDM relatives were TG = 148 +/- 24mg/dl, T-Chol = 244 +/- 10.7mg/dl, HDL-C = 34.2 +/- 2.5mg/dl; lipids in the control group were TG = 84.8 +/- 10.1mg/dl, T-Chol = 167 +/- 10.2mg/dl, HDL-C = 44.4 +/- 2.6mg/dl. Electrophoretic pattern showed type IIa (30.7%) and IIb (61.5%) hyperlipidemias in the NIDDM relatives. In this group, there was a positive and significant association between basal insulin and DBP (r = 0.67; p < 0.01), and between DBP and both TG (r = 0.74; p < 0.01)) and VLDL-C (r = 0.58; p < 0.05). It was also obtained a negative association between basal insulin and HDL-C (r = -0.89; p < 0.001). These data suggest that hyperinsulinemia in association with lipid abnormalities could appear early (before the development of Impaired Glucose Tolerance and Diabetes) in first degree relatives of NIDDM patients.
为了确定非胰岛素依赖型糖尿病(NIDDM)患者一级亲属中最常见的血脂异常情况,以及其与他们的糖耐量状态和高胰岛素血症的关联,我们已开始按照美国糖尿病协会关于核心家庭研究的指南,对NIDDM家系成员进行检查。在一个第二代有2名NIDDM同胞、第三代有4名NIDDM同胞的大家庭中,我们评估了14名一级亲属以及15名年龄和性别匹配、无糖尿病家族史的健康对照者。NIDDM亲属组的体重指数(BMI)为31.8±3.9kg/m²,收缩压(SBP)为128±18.2mmHg,舒张压(DBP)为84±12.7mmHg。亲属组和对照组均接受了2小时75克口服葡萄糖耐量试验(OGTT)以测定血糖和胰岛素。尽管NIDDM亲属中无人有糖耐量受损(IGT),但NIDDM亲属组的血糖曲线下面积(GA)和胰岛素曲线下面积(IA)均更大(p<0.01)。在OGTT的0分钟和120分钟时,胰岛素/葡萄糖比值也更高(p<0.01),这可能是胰岛素抵抗的间接证据。NIDDM亲属的空腹血脂为甘油三酯(TG)=148±24mg/dl,总胆固醇(T-Chol)=244±10.7mg/dl,高密度脂蛋白胆固醇(HDL-C)=34.2±2.5mg/dl;对照组的血脂为TG=84.8±10.1mg/dl,T-Chol=167±10.2mg/dl,HDL-C=44.4±2.6mg/dl。电泳图谱显示NIDDM亲属中IIa型(30.7%)和IIb型(61.5%)血脂异常。在该组中,基础胰岛素与DBP之间存在显著正相关(r=0.67;p<0.01),DBP与TG(r=0.74;p<0.01)和极低密度脂蛋白胆固醇(VLDL-C)(r=0.58;p<0.05)之间也存在显著正相关。基础胰岛素与HDL-C之间还存在负相关(r=-0.89;p<0.001)。这些数据表明,高胰岛素血症与脂质异常可能在NIDDM患者的一级亲属中早期出现(在糖耐量受损和糖尿病发生之前)。